Transcript Slide 1
Severe Sepsis
Initial recognition and resuscitation
Issued August 2010
Expected Practice
Assess all patients and immediately
notify physician when a patient
presents with risk factors for sepsis.
Severe Sepsis: Initial recognition and
resuscitation
2
Clinical Findings
Documented or suspected infection
Two or more SIRS criteria
At least one indicator of tissue
hypoperfusion or related acute organ
dysfunction
Severe Sepsis: Initial recognition and
resuscitation
3
SIRS criteria
Heart rate > 90 beats per minute
Temperature < 36°C (98.8°F) or >
38.3°C (100.4°F)
Respiratory rate > 20 breaths per
minute
White blood cell count > 12,000/mm3 or
< 4000 mm
Severe Sepsis: Initial recognition and
resuscitation
4
Tissue hypoperfusion
Sepsis related acute organ failure
Acute altered
mental status
SBP <90mmHg or
MAP < 70mmHg or
SBP Decrease of 40
mmHg
Blood glucose >
140 mg/dL, nondiabetic patients
Arterial hypoxemia
Severe Sepsis: Initial recognition and
resuscitation
Acute oliguria
Creatinine increase
above baseline
Coagulation
abnormalities
Ileus
Thrombocytopenia
Hyoperbilirubinemia
5
Expected Practice
Obtain serum lactate measurements.
Hyperlactatemia is defined as lactic acid level > 4.
Obtain blood cultures as well as cultures
from all potential sites of infection prior to
initiating broad spectrum antibiotics
Blood cultures should be drawn prior to initiation of
antibiotic therapy and within 1 hour of sepsis diagnosis
Severe Sepsis: Initial recognition and
resuscitation
6
Expected Practice
Evaluate for and remove other potential
sources of infection
Severe Sepsis: Initial recognition and
resuscitation
7
Maintain Therapeutic Endpoints
MAP at >65 mmHg
CVP 8-12 mmHg
Central venous or mixed venous
oxygen saturation > 70%
Severe Sepsis: Initial recognition and
resuscitation
8
Expected Practice
Administer fluids to maintain:
Mean arterial pressure at >65 mmHg
Central venous pressure (CVP)
8-12 mmHg
Central venous or mixed venous oxygen
saturation > 70%.
Severe Sepsis: Initial recognition and
resuscitation
9
Expected Practice
Administer vasopressors if necessary
to achieve a mean arterial pressure of
65 mmHg
If Venous Oxygen saturation goal not
attained consider;
Additional fluids
Blood transfusion
Dobutamine infusion
Severe Sepsis: Initial recognition and
resuscitation
10
Expected Practice
Maintain blood glucose levels at
< 150 mg/dL.
Consider administration of human
recombinant activated protein C
Note: Administration of human recombinant activated protein C
(drotrecogin alfa activated) is no longer recommended. The FDA sent
out notification on October 25, 2011 that Eli Lilly has withdrawn this
drug from the market.
Severe Sepsis: Initial recognition and
resuscitation
11
Scope and Impact of the
Problem
Severe sepsis is a major healthcare
problem that affects millions of people
around the world each year with an
extremely high mortality rate of 3060%.
Severe Sepsis: Initial recognition and
resuscitation
12
Scope and Impact of the
Problem
Mortality from sepsis is greater than that
of breast cancer, lung cancer, and
colon cancer combined and is the
number one cause of death in the noncoronary ICU. The incidence of severe
sepsis is expected to double over the
next 25-30 years.
Severe Sepsis: Initial recognition and
resuscitation
13
Supporting Evidence
More than 750,000 cases of severe sepsis
occurred annually
Sepsis can rapidly progress to severe sepsis
to septic shock within 24 hours
Severe Sepsis: Initial recognition and
resuscitation
14
Supporting evidence
Treatment should be initiated
regardless of where the patient is
located within the hospital.
Patients treated aggressively within the
first 6 hours of presentation have lower
mortality
Severe Sepsis: Initial recognition and
resuscitation
15
Supporting evidence
Serum lactate levels can be elevated in
the setting of a normal or increased
cardiac output.
The measurement of serum lactate can reflect
occult decreases in global tissue perfusion and
may be an indicator of organ dysfunction.
The presence and the clearance rate of lactate
are associated with increases in patient
morbidity and mortality.
Severe Sepsis: Initial recognition and
resuscitation
16
Supporting evidence
Early administration of appropriate
antibiotics decreases mortality in
patients with Gram- positive and
negative bacteremias.
Empiric broad spectrum antibiotics
should be initiated prior to identification
of the infecting organism
Reassess after 48-72 hours based on culture
results and clinical data.
Severe Sepsis: Initial recognition and
resuscitation
17
Supporting evidence
Surviving Sepsis Campaign guidelines state
that the goal of the first 6 hours of treatment
Achieve and maintain a CVP of 8-12 mm Hg or 12-15
mm Hg for patients receiving mechanical ventilation and
a MAP of at least 65 mm Hg with fluid resuscitation.
Dobutamine is identified as the medication of
choice to increase cardiac output to normal
levels or to improve lactate clearance
Severe Sepsis: Initial recognition and
resuscitation
18
Supporting evidence
No benefit has been shown for
increasing cardiac output above
physiologic normal levels.
Available data do not support the use
of low dose dopamine for renal
protection
Severe Sepsis: Initial recognition and
resuscitation
19
Supporting evidence
Colloids have not been shown to be of
more benefit than crystalloid for fluid
resuscitation.
Severe Sepsis: Initial recognition and
resuscitation
20
Supporting evidence
Fluid replacement should be optimized
before vasopressors are started.
Norepinephrine or dopamine are
identified as the initial vasopressors to
increase vascular tone and blood
pressure.
Severe Sepsis: Initial recognition and
resuscitation
21
Supporting evidence
Meta analyses concluded that administration
of high dose corticosteroids are of no benefit
or may be detrimental to patients with septic
shock.
In vasopressor dependent shock, low-dose
exogenous cortisol may improve the uptake
of the patient’s own and the exogenously
administered sympathetic stimulants when
serum cortisol levels are low.
Severe Sepsis: Initial recognition and
resuscitation
22
Supporting evidence
Glucose levels within 80-110 mg/dL
may decrease morbidity and morality in
a surgical population.
Glucose levels < 150mg/dL showed
reduced morbidity in critically ill medical
patients.
Severe Sepsis: Initial recognition and
resuscitation
23
Supporting evidence
Administration of human recombinant
activated protein C (drotrecogin alfa
activated) is no longer recommended. The
FDA sent out notification on October 25,
2011 that Eli Lilly has withdrawn this drug
from the market. In a recently completed
clinical trial (PROWESS-SHOCK trial), the
drug failed to show a survival benefit for
patients with severe sepsis and septic shock.
Severe Sepsis: Initial recognition and
resuscitation
24
Actions for Nursing
Practice
Educate all nursing staff on the risk
factors and clinical signs of sepsis.
Severe Sepsis: Initial recognition and
resuscitation
25
Actions for Nursing
Practice
Create an interdisciplinary team to
develop protocols or guidelines.
Severe Sepsis: Initial recognition and
resuscitation
26
Actions for Nursing
Practice
Consider development of a rapid
response team to facilitate prompt
identification of patients with sepsis.
Severe Sepsis: Initial recognition and
resuscitation
27
Need More Information or
Help?
For additional information/assistance
go to www.aacn.org then select PRN.
Severe Sepsis: Initial recognition and
resuscitation
28